CVS rallies on turnaround momentum and EPS growth, while CI is a defensive play with stable returns and a focused healthcare ...

Cigna trades at $313 per share and has moved almost in lockstep with the market over the last six months. The stock has lost ...

Cigna’s first-quarter report shows strong numbers, but Barclays warns the road ahead could get rocky. Barclays highlights ...

Review stock chart history to analyze past trends and find the highest Cigna price. This page offers a complete view of CI stock history, enabling you to study performance over specific time frames.

The addition of low-intensity electric tumor treating fields (TTFields) therapy to first-line standard chemotherapy was ...

Cigna’s latest SWOT analysis shows a company flexing its market muscles despite tricky healthcare headwinds. Cigna’s strong ...